Chemours topped Q2 estimates with $227M EBITDA, led by record TSS segment earnings. Management lifted 2026 EBITDA guidance to $810M-$850M, above consensus.
Alpha Score of 44 reflects weak overall profile with moderate momentum, poor value, moderate quality, moderate sentiment.
Chemours posted adjusted EBITDA of $227 million in the second quarter, topping the $210 million consensus. Revenue of $1.38 billion came in ahead of the $1.34 billion analyst forecast, roughly flat from a year earlier.
The Thermal & Specialized Solutions segment delivered record quarterly earnings. Segment EBITDA reached $103 million, up 15% from a year ago. CEO Denise Dignam said pricing and volume in automotive and refrigerant end markets drove the gain.
Titanium Technologies posted weaker results. EBITDA fell to $119 million from $130 million in the year-ago period. Lower TiO2 pricing in Europe and Asia pressured margins.
Management raised its full-year 2026 adjusted EBITDA guidance. The new range is $810 million to $850 million, up from the prior $760 million to $820 million. CFO Shane Hostetter said the $830 million midpoint stands above the $800 million consensus.
The Advanced Performance Materials segment produced EBITDA of $23 million, up from $17 million a year ago. Stronger demand for high-performance polymers used in semiconductor and aerospace applications helped.
Free cash flow in the quarter was $96 million, down from $131 million in the year-ago period. Hostetter attributed the decline to higher working capital tied to inventory builds in TSS ahead of the seasonal peak. He said the company still expects full-year free cash flow conversion above 50%.
Chemours ended the quarter with net leverage at 2.9 times, within its target range of 2.0 to 3.0 times. The next bond maturity comes due in 2028.
Analysts on the call pressed on TiO2 pricing recovery. Dignam said pricing is bottoming in the current quarter, with modest improvement expected in the fourth quarter as destocking in Europe and Asia runs its course. She pointed to a 2% sequential volume increase in TiO2 in the second quarter as a sign that demand is stabilizing.
Truist analyst Peter Osterland asked whether the TSS segment could sustain its current margins if refrigerant demand slows after 2027 regulatory deadlines. Dignam said the regulatory tailwind from the AIM Act phase-down extends beyond 2027. She added that Opteon adoption in new automotive air conditioning systems remains on an upward trajectory.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.